Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India

Data supporting use of concurrent chemoradiation in locally advanced lung cancers comes from clinical trials from developed countries. Applicability and outcomes of such schedules in developing countries is not widely reported. There are various challenges in delivering chemoradiation in locally adv...

Full description

Bibliographic Details
Main Author: Sushma Agrawal
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2013-01-01
Series:South Asian Journal of Cancer
Subjects:
Online Access:http://journal.sajc.org/article.asp?issn=2278-330X;year=2013;volume=2;issue=4;spage=265;epage=271;aulast=Agrawal
id doaj-13ff84221b764ccfab7178f9c5a0b221
record_format Article
spelling doaj-13ff84221b764ccfab7178f9c5a0b2212020-12-02T17:19:54ZengThieme Medical and Scientific Publishers Pvt. Ltd.South Asian Journal of Cancer2278-330X2278-43062013-01-012426527110.4103/2278-330X.119893Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in IndiaSushma AgrawalData supporting use of concurrent chemoradiation in locally advanced lung cancers comes from clinical trials from developed countries. Applicability and outcomes of such schedules in developing countries is not widely reported. There are various challenges in delivering chemoradiation in locally advanced non small cell lung cancer in developing countries which is highlighted by an audit of patients treated with chemoradiation in our center. This article deals with the challenges in the context of a developing country. We conclude that sequential chemoradiotherapy is better tolerated than concurrent chemoradiation in Indian patients with locally advanced non-small cell lung cancers. Patients with stage IIIa, normal weight or overweight, and adequate baseline pulmonary function should be offered concurrent chemoradiation.http://journal.sajc.org/article.asp?issn=2278-330X;year=2013;volume=2;issue=4;spage=265;epage=271;aulast=AgrawalLocally advanced non-small cell Lung cancerconcurrent chemoradiationdeveloping countriesnon-small-cell lung cancerchemoradiation
collection DOAJ
language English
format Article
sources DOAJ
author Sushma Agrawal
spellingShingle Sushma Agrawal
Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India
South Asian Journal of Cancer
Locally advanced non-small cell Lung cancer
concurrent chemoradiation
developing countries
non-small-cell lung cancer
chemoradiation
author_facet Sushma Agrawal
author_sort Sushma Agrawal
title Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India
title_short Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India
title_full Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India
title_fullStr Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India
title_full_unstemmed Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India
title_sort challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in india
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
series South Asian Journal of Cancer
issn 2278-330X
2278-4306
publishDate 2013-01-01
description Data supporting use of concurrent chemoradiation in locally advanced lung cancers comes from clinical trials from developed countries. Applicability and outcomes of such schedules in developing countries is not widely reported. There are various challenges in delivering chemoradiation in locally advanced non small cell lung cancer in developing countries which is highlighted by an audit of patients treated with chemoradiation in our center. This article deals with the challenges in the context of a developing country. We conclude that sequential chemoradiotherapy is better tolerated than concurrent chemoradiation in Indian patients with locally advanced non-small cell lung cancers. Patients with stage IIIa, normal weight or overweight, and adequate baseline pulmonary function should be offered concurrent chemoradiation.
topic Locally advanced non-small cell Lung cancer
concurrent chemoradiation
developing countries
non-small-cell lung cancer
chemoradiation
url http://journal.sajc.org/article.asp?issn=2278-330X;year=2013;volume=2;issue=4;spage=265;epage=271;aulast=Agrawal
work_keys_str_mv AT sushmaagrawal challengesinoptimizingchemoradiationinlocallyadvancednonsmallcelllungcancersinindia
_version_ 1724404824894603264